Registration Dossier Structure in Russia Under Resolution No. 1684

1. Key takeaways

Under Government Resolution of the Russian Federation No. 1684 on the state registration rules for medical devices, national registration is a comprehensive decision built on six classes of grounds set out in p. 5: technical testing, toxicological studies and clinical trials, which together form the three types of conformity assessment, production inspection, analysis of the manufacturer’s evidence materials, and expert review of quality, effectiveness and safety. A registration dossier accepted for review is therefore never a loose compilation of certificates. It is an argumentative structure in which every claim made about the device is matched to a specific piece of evidence, and the expert organisation will read the file precisely as a chain of claim-to-evidence correspondences.

The practical consequence is that dossier assembly should start from a mapping table rather than from a folder of accumulated documents. Each performance claim in the application, each statement in the instructions for use and each marking element must trace back to a page and a clause of a test report, a toxicological study or a clinical evaluation. Where a claim lacks supporting evidence, the review does not fail silently: the gap converts into a request for additional documents, and every such request consumes working days inside the statutory review timeline. Building the correspondence table before testing begins is the most effective way to keep the dossier coherent, and it also protects the budget, because a well-mapped dossier avoids repeated supplementation cycles.

2. Legal basis

The core instruments governing the composition of the dossier and the conformity assessment documents it must contain are summarised in the table below.

3. Expert insights

Insight 1: expert review examines correspondences, not stacks of paper. Order No. 421n, p. 2, defines the four categories of conformity assessment result documents: the technical test report (including the version applicable to in vitro diagnostic devices), the toxicological study report, the evaluation report on clinical trial results, and the evaluation report on IVD clinical trial results. The expert organisation compares these documents with the claims in the application line by line. Any statement that cannot be traced to a result document becomes a request for supplementary materials, and each supplementary cycle adds calendar time to the project. Reviewers in Russia look for internal logic: the same device version, the same intended use and the same performance figures appearing consistently across the application, the test reports and the operating documents.

Insight 2: production inspection and QMS certification are not the same thing. A QMS certificate issued against GOST ISO 13485-2017 demonstrates organisational capability across the manufacturer’s processes. Production inspection, by contrast, targets the specific registration unit and verifies that this device can be reproducibly manufactured under the conditions of the inspected site. The two mechanisms are complementary and cannot replace each other. A strong QMS certificate does not exempt the specific unit from inspection, and a favourable inspection report does not certify the management system as a whole. Sponsors should plan both and budget for both rather than assuming one covers the other.

Insight 3: internal inconsistency of the dossier is a common cause of refusal. The six classes of grounds listed in p. 5 of Resolution No. 1684 must all point to one and the same version of the product. If the prototype used for technical testing is an old version, the instructions for use have been updated to a newer version and the labels come from yet another batch, the reviewer will inevitably request clarification. Such mismatches are easy to prevent and expensive to fix after submission, because correcting them usually means re-issuing documents, re-aligning annexes and in some cases repeating parts of testing on the current version.

4. Practical recommendations

1. Build a claim-to-evidence correspondence table as the backbone of the dossier: map every performance claim to the page and clause of a specific test report, study or evaluation.
2. Lock the prototype, the instructions for use and the label to one single version before launching any testing, and record the version identifiers in the project file.
3. Manage document validity as part of dossier preparation: QMS certificates, test reports, powers of attorney and registration extract documents must all be valid on the date of submission.
4. Assign one owner for dossier coherence who checks cross-references, annex numbering and version identifiers before each submission milestone.
5. Re-run the correspondence check after every change, however small, because even minor editorial edits can break the alignment between claims and evidence.
6. Keep a written rationale for every exclusion, so that reviewers understand why a particular ground under p. 5 is not relied upon for the device type.

5. Verification checklist

• □ A claim-to-evidence correspondence table has been prepared and covers all performance claims
• □ Technical test report, toxicological study report and clinical evaluation reports are complete and follow the annexes of Order No. 421n
• □ Production inspection has been arranged, or the applicability of QMS documents has been justified
• □ Prototype, instructions for use and label versions are mutually consistent
• □ Powers of attorney, QMS certificates and company registration documents are valid on the submission date

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers and authorised representatives preparing registration dossiers for the Russian market, from claim-to-evidence mapping and conformity assessment document preparation to the alignment of technical testing, toxicological and clinical materials under the current national rules. Our team helps you structure the file so that every claim is verifiable and every version is consistent before submission. For tailored support on Russian documentation and conformity files, contact us at info@grzanglobal.com.